Completed PHASE4 INTERVENTIONAL 3-arm NCT01824758

Effect of Esmolol on Pain Due to Rocuronium

The Effect of Esmolol on Pain Due to Rocuronium Injection Pain

Sponsor: Ankara Diskapi Training and Research Hospital

Interventions Esmolol Lidocaine Placebo rocuronium

Updated 8 times since 2017 Last updated: Oct 2, 2019 Started: Mar 31, 2013 Primary completion: Apr 30, 2013 Completion: May 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01824758, this PHASE4 trial focuses on Injection Site Irritation and remains completed. Sponsored by Ankara Diskapi Training and Research Hospital, it has been updated 8 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Nov 2019 — Jan 2021 [monthly]

Completed PHASE4

Status: Unknown Status → Completed

▶ Show 3 earlier versions

Jun 2018 — Nov 2019 [monthly]

Unknown Status PHASE4
Apr 2018 — Jun 2018 [monthly]

Unknown Status PHASE4
Jan 2017 — Apr 2018 [monthly]

Unknown Status PHASE4

First recorded

Mar 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ankara Diskapi Training and Research Hospital

Data source: Ankara Diskapi Training and Research Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ankara, Turkey (Türkiye)